Tailoring CONSORT-SPI to improve the reporting of smoking cessation intervention trials: An expert consensus study.

RCTs expert consensus interventions reporting smoking cessation trials

Journal

Addiction (Abingdon, England)
ISSN: 1360-0443
Titre abrégé: Addiction
Pays: England
ID NLM: 9304118

Informations de publication

Date de publication:
Feb 2024
Historique:
received: 17 11 2022
accepted: 20 07 2023
medline: 12 1 2024
pubmed: 19 9 2023
entrez: 19 9 2023
Statut: ppublish

Résumé

Inadequate reporting of smoking cessation intervention trials is common and leads to significant challenges for researchers. The aim of this study was to tailor CONSORT (Consolidated Standards of Reporting Trials)-SPI (Social and Psychological Interventions) guidelines to improve reporting of trials of behavioural interventions to promote smoking cessation. Informed by missing data from the IC-SMOKE (Intervention and Comparison group support provided in SMOKing cEssation) systematic review project, this study used a multi-stage Delphi process to examine which items could be added or modified to improve the reporting of smoking cessation trials. The first stage involved an on-line survey of 17 international experts in smoking cessation and trial methodology voting on the importance of items for inclusion in the updated guidelines. This was followed by a face-to-face expert consensus meeting attended by 15 of these experts, where the final inclusion and exclusion of new items and modifications were agreed upon. A nine-point Likert scale was used to establish consensus, with suggested modifications requiring agreement of 75% or more. Disagreements in the first stage were presented again at the second stage for discussion and a second round of voting. Only items which reached the threshold for agreement were included. The experts agreed on the inclusion of 10 new items and the specification of 12 existing items. This included modifications that could apply to trials more widely (e.g. the rationale for the comparator), but also modifications that were very specific to smoking cessation trials (e.g. the reporting of smoking cessation outcomes). A Delphi study has developed a modified CONSORT-SPI guideline (CONSORT-SPI-SMOKE) to improve the reporting of trials of behavioural interventions to promote smoking cessation.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
Inadequate reporting of smoking cessation intervention trials is common and leads to significant challenges for researchers. The aim of this study was to tailor CONSORT (Consolidated Standards of Reporting Trials)-SPI (Social and Psychological Interventions) guidelines to improve reporting of trials of behavioural interventions to promote smoking cessation.
METHOD METHODS
Informed by missing data from the IC-SMOKE (Intervention and Comparison group support provided in SMOKing cEssation) systematic review project, this study used a multi-stage Delphi process to examine which items could be added or modified to improve the reporting of smoking cessation trials. The first stage involved an on-line survey of 17 international experts in smoking cessation and trial methodology voting on the importance of items for inclusion in the updated guidelines. This was followed by a face-to-face expert consensus meeting attended by 15 of these experts, where the final inclusion and exclusion of new items and modifications were agreed upon. A nine-point Likert scale was used to establish consensus, with suggested modifications requiring agreement of 75% or more. Disagreements in the first stage were presented again at the second stage for discussion and a second round of voting. Only items which reached the threshold for agreement were included.
RESULTS RESULTS
The experts agreed on the inclusion of 10 new items and the specification of 12 existing items. This included modifications that could apply to trials more widely (e.g. the rationale for the comparator), but also modifications that were very specific to smoking cessation trials (e.g. the reporting of smoking cessation outcomes).
CONCLUSIONS CONCLUSIONS
A Delphi study has developed a modified CONSORT-SPI guideline (CONSORT-SPI-SMOKE) to improve the reporting of trials of behavioural interventions to promote smoking cessation.

Identifiants

pubmed: 37724014
doi: 10.1111/add.16340
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

225-235

Subventions

Organisme : Medical Research Council
ID : G0901474
Pays : United Kingdom
Organisme : Chief Scientist Office
ID : HSRU1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : A25405
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C50862
Pays : United Kingdom

Informations de copyright

© 2023 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.

Références

Pirosca S, Shiely F, Clarke M, Treweek S. Tolerating bad health research: the continuing scandal. Trials. 2021;23:458.
Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMHJ. 2014;348:g1687.
Fanshawe TR, Hartmann-Boyce J, Perera R, Lindson N. Competitions for smoking cessation. Cochrane Database Syst Rev. 2019;2:CD013272.
Notley C, Gentry S, Livingstone-Banks J, Bauld L, Perera R, Hartmann-Boyce J. Incentives for smoking cessation. Cochrane Database Syst Rev. 2019;7:CD004307.
Ussher MH, Faulkner GEJ, Angus K, Hartmann-Boyce J, Taylor AH. Exercise interventions for smoking cessation. Cochrane Database Syst Rev. 2019;10:CD002295.
Vijayaraghavan M, Elser H, Frazer K, Lindson N, Apollonio D. Interventions to reduce tobacco use in people experiencing homelessness. Cochrane Database Syst Rev. 2020;12:CD013413.
Montgomery P, Grant S, Mayo-Wilson E, Macdonald G, Michie S, Hopewell S, et al. Reporting randomised trials of social and psychological interventions: the CONSORT-SPI 2018 extension. Trials. 2018;19:407.
de Bruin M, Black N, Javornik N, Viechtbauer W, Eisma MC, Hartman-Boyce J, et al. Underreporting of the active content of behavioural interventions: a systematic review and meta-analysis of randomised trials of smoking cessation interventions. Health Psychol Rev. 2021;15:195-213.
Moher D, Schulz KF, Simera I, Altman DG. Guidance for developers of health research reporting guidelines. PLOS Med. 2010;7:e1000217.
de Bruin M, Viechtbauer W, Eisma MC, Hartmann-Boyce J, West R, Bull E, et al. Identifying effective behavioural components of intervention and comparison group support provided in SMOKing cEssation (IC-SMOKE) interventions: a systematic review protocol. Syst Rev. 2016;5:77.
Bricca A, Swithenbank Z, Scott N, Treweek S, Johnston M, Black N, et al. Predictors of recruitment and retention in randomized controlled trials of behavioural smoking cessation interventions: a systematic review and meta-regression analysis. Addiction. 2022;117:299-311.
West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction. 2005;100:299-303.
West R. PAT: an on-line paper authoring tool for writing up randomized controlled trials. Addiction. 2021;116:1938-1940.
Williamson PR, Altman DG, Bagley H, Barnes KL, Blazeby JM, Brookes ST, et al. The COMET handbook: version 1.0. Trials. 2017;18:280.
OMBEA Response. Ombea AB; Stockholm, Sweden. 2018.
Freedland KE, King AC, Ambrosius WT, Mayo-Wilson E, Mohr DC, Czajkowski SM, et al. National Institutes of Health Office of Behavioural and Social Sciences Research Expert Panel on Comparator Selection in Behavioural and Social Science Clinical Trials The selection of comparators for randomized controlled trials of health-related behavioural interventions: recommendations of an NIH expert panel. J Clin Epidemiol. 2019;110:74-81.
de Bruin M. IC-SMOKE: control group support questionnaire. Available at: https://osf.io/e834t. Accessed 01 Oct 2022.
de Bruin M, Viechtbauer W, Schaalma HP, Kok G, Abraham C, Hospers HJ. Standard care impact on effects of highly active antiretroviral therapy adherence interventions: a meta-analysis of randomized controlled trials. Arch Intern Med. 2010;170:240-250.

Auteurs

Zoe Swithenbank (Z)

Public Health Institute, Liverpool John Moores University, Liverpool, UK.

Alessio Bricca (A)

Research Unit for Musculoskeletal Function and Physiotherapy, University of Southern Denmark, Odense, Denmark.
The Research Unit PROgrez, Naestved-Slagelse-Ringsted Hospitals, Slagelse, Denmark.

Nicola Black (N)

National Drug and Alcohol Research Centre, University of New South Wales Sydney, Kensington, Australia.

Jamie Hartmann Boyce (J)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Marie Johnston (M)

Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, Scotland, UK.

Neil Scott (N)

Medical Statistics Team, University of Aberdeen, Aberdeen, Scotland, UK.

Robert West (R)

Health Behaviour Research Centre, Department of Epidemiology and Public Health, University College London, London, UK.

Ryan J Courtney (RJ)

National Drug and Alcohol Research Centre, University of New South Wales Sydney, Kensington, Australia.

Shaun Treweek (S)

Health Services Research Unit, University of Aberdeen, Aberdeen, Scotland, UK.

Susan Michie (S)

Centre for Behaviour Change, University College London, London, UK.

Marijn de Bruin (M)

IQ Healthcare, Institute of Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH